GlassScriptPhysician profile
Kenneth Albert Malament
NPI 1871781849
$39,344.33
in general payments reported to CMS, 2019-2025
7 companies · $14.41 in 2025
The $14.41 reported for 2025 was less than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,423 · 2020: $15K · 2021: $9,339 · 2022: $7,414 · 2023: $1,599 · 2024: $4,046 · 2025: $14.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,369 · Gift: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,368.81 |
| Gift | $290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $37,979.29 | 2019-2024 | Adhese Univ. System Vivapen 1x2ml/100 |
| Nobel Biocare USA | $983.10 | 2022 | |
| Carestream Dental, LLC | $206.00 | 2022 | |
| Biohorizons Implant Systems INC. | $85.97 | 2023 | Biohorizons |
| Zimvie INC. | $75.56 | 2022 | |
| Dentsply Sirona INC | $14.41 | 2025 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Malament listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.